Characterization of the Relationship of Inotuzumab Ozogamicin Exposure With Efficacy and Safety End Points in Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia

Chen J, Haughey M, Vandendries E, DeAngelo DJ, Kantarjian HM, Ruiz-Garcia A. Clin Transl Sci. 2021 Jan;14(1):184-193. doi: 10.1111/cts.12841. Epub 2020 Aug 18.